Neurogastroenterology and Motility

PAR4: A new role in the modulation of visceral nociception
pp. 1129-1132(4)
Author: bradesi, s.

Biofeedback therapy in fecal incontinence and constipation
pp. 1133-1141(9)
Authors: enck, p.; van der voort, i. r.; klosterhalfen, s.

Evidence for oesophageal visceral hypersensitivity and aberrant symptom referral in patients with globus
pp. 1142-e96(-1141)
Authors: chen, c. l.; szczesniak, m. m.; cook, i. j.

Catecholamine and cortisol levels during sleep in women with irritable bowel syndrome
pp. 1148-e97(-1147)
Authors: burr, r. l.; jarrett, m. e.; cain, k. c.; jun, s.-e.; heitkemper, m. m.

Personality differences affect brainstem autonomic responses to visceral pain
pp. 1155-e98(-1154)
Authors: paine, p.; worthen, s. f.; gregory, l. j.; thompson, d. g.; aziz, q.

Swallowing and respiratory pattern in young healthy individuals recorded with high temporal resolution
pp. 1163-e101(-1162)
Authors: boden, k.; hardemark cedborg, a. i.; eriksson, l. i.; hedström, h. Witt; kuylenstierna, r.; sundman, e.; ekberg, o.

Irritable bowel syndrome is more frequent in patients hospitalized for ischaemic colitis: results of a case-control study
pp. 1170-e102(-1169)
Authors: hervé, s.; beaugerie, l.; bouhnik, y.; savoye, g.; colombel, j.-f.; dyard, f.; hourmand-ollivier, i.; dao, t.; vial, m.; lerebours, e.

The nitric oxide synthase inhibitor, N^g-nitro-l-arginine-methyl-ester, attenuates the delay in gastric emptying induced by hyperglycaemia in healthy humans
pp. 1175-e103(-1174)
Authors: kuo, p.; gentilcore, d.; nair, n.; stevens, j. e.; wishart, j. m.; lange, k.; gilja, o. h.; hausken, t.; horowitz, m.; jones, k. l.; rayner, c. k.

Relationship between symptom pattern, assessed by the PAGI-SYM^© questionnaire, and gastric sensorimotor dysfunction in functional dyspepsia
pp. 1183-e105(-1182)
Authors: kindt, s.; dubois, d.; van oudenhove, l.; caenepeel, p.; arts, j.; bisschops, r.; tack, j.

Protease-activated receptor-4 (PAR₄): a role as inhibitor of visceral pain and hypersensitivity
pp. 1189-e107(-1188)
Authors: augé, c.; balz-hara, d.; steinhoff, m.; vergnolle, n.; cenac, n.

Increased colonic transit in rats produced by a combination of a cholinesterase inhibitor with a 5-HT₄ receptor agonist
pp. 1197-e108(-1196)
Authors: campbell-dittmeyer, k.; hicks, g. a.; earnest, d. l.; greenwood-van meerveld, b.

The multi-herbal drug STW 5 (Iberogast^®) has prosecretory action in the human intestine
pp. 1203-e110(-1202)
Authors: krueger, d.; gruber, l.; buhner, s.; zeller, f.; langer, r.; seidl, s.; michel, k.; schemann, m.

Increased mucosal nitric oxide production in ulcerative colitis is mediated in part by the enteroglial-derived S100B protein
pp. 1209-e112(-1208)
Authors: cirillo, c.; sarnelli, g.; esposito, g.; grosso, m.; petruzzelli, r.; izzo, p.; calì, g.; d'armiento, f. p.; rocco, a.; nardone, g.; iuvone, t.; steardo, l.; cuomo, r.

Activation of protease-activated receptor-4 inhibits the intrinsic excitability of colonic dorsal root ganglia neurons
pp. 1218-1221(4)
Authors: karanjia, r.; spreadbury, i.; bautista-cruz, f.; tsang, m. e.; vanner, s.

5-HT₃ receptors mediate the time-dependent vagal afferent modulation of nociception during chronic food allergen-sensitized visceral hyperalgesia in rats
pp. 1222-e113(-1221)
Authors: chen, s.; li, j.; zhang, l.; dong, x.; gao, w.; mo, j.; chen, h.; xiao, s.; li, y.

Loss of enteric neurons accompanied by decreased expression of GDNF and PI3K/Akt pathway in diabetic rats
pp. 1229-e114(-1228)
Authors: du, f.; wang, l.; qian, w.; liu, s.